Get the Stockscreener App
1.87
0.54%
0.01
After Hours:
1.87
Heartbeam Inc stock is traded at $1.87, with a volume of 1.18M.
It is up +0.54% in the last 24 hours and down -36.18% over the past month.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
See More
Previous Close:
$1.86
Open:
$1.91
24h Volume:
1.18M
Relative Volume:
0.10
Market Cap:
$64.41M
Revenue:
-
Net Income/Loss:
$-20.34M
P/E Ratio:
-2.6829
EPS:
-0.697
Net Cash Flow:
$-15.59M
1W Performance:
-15.00%
1M Performance:
-36.18%
6M Performance:
+47.24%
1Y Performance:
-12.62%
1-Day Range:
$1.86
$2.03
1-Week Range:
$1.86
$2.24
52-Week Range:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.87 | 64.07M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-08-25 | Initiated | H.C. Wainwright | Buy |
| Oct-31-25 | Initiated | Roth Capital | Buy |
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
Market Review: What are HeartBeam Inc Equity Warrants recent SEC filings showingSell Signal & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Heartbeam, Inc. Appoints Bryan Humbarger as Chief Commercial Officer, Effective January 22, 2026 - marketscreener.com
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - TipRanks
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - BioSpace
HeartBeam appoints Bryan Humbarger as chief commercial officer - Investing.com
Sectors Review: Can HeartBeam Inc maintain its current growth rate2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Review: Is GSR III Acquisition Corp. showing insider buyingWeekly Stock Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Activity Recap: How does Roper Technologies Inc perform in inflationary periodsMarket Trend Review & Breakout Confirmation Alerts - baoquankhu1.vn
Recap Report: Can HeartBeam Inc Equity Warrant stock sustain revenue growthPortfolio Gains Report & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Aug Gainers: Should value investors consider HeartBeam Inc2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - TradingView — Track All Markets
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup - NewMediaWire
About Us - FinancialContent
How HeartBeam Inc. stock performs in interest rate cyclesQuarterly Market Review & Fast Entry High Yield Stock Tips - Улправда
Will HeartBeam Inc. stock benefit from automationQuarterly Market Summary & Technical Entry and Exit Tips - ulpravda.ru
Is HeartBeam Inc. Equity Warrant stock safe for conservative investorsMarket Growth Review & Accurate Entry/Exit Alerts - ulpravda.ru
What sentiment indicators say about HeartBeam Inc. stock2025 Technical Overview & Short-Term Trading Alerts - Улправда
Can HeartBeam Inc. Equity Warrant stock outperform in 2025 bull marketQuarterly Trade Report & Stepwise Trade Signal Guides - Улправда
Is HeartBeam Inc. Equity Warrant stock a safe haven assetRecession Risk & Short-Term High Return Strategies - Улправда
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
AeroVironment Stock Surges: Military Gains Explored - StocksToTrade
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Retail Activity & Daily Market Momentum Tracking - ulpravda.ru
Can HeartBeam Inc. stock hit analyst price targetsGap Fill Strategies & Low Risk Capital Growth - ulpravda.ru
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - NewMediaWire
HeartBeam (NASDAQ: BEAT) to attend JP Morgan 2026 annual healthcare conference - MSN
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - TradingView — Track All Markets
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference - 01net
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - FinancialContent
Trend Recap: Is HeartBeam Inc stock recession proofMarket Trend Review & Weekly Watchlist for Consistent Profits - moha.gov.vn
How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsGlobal Trade Effects & Small Budget Trading Ideas - bollywoodhelpline.com
Pharma News: What sentiment indicators say about HeartBeam Inc stockRisk Management & High Conviction Investment Ideas - moha.gov.vn
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
Major HeartBeam Investor Makes Bold Move With Eye-Catching Stock Sale - TipRanks
Heartbeam Insider Sold Shares Worth $895,000, According to a Recent SEC Filing - marketscreener.com
Earnings Beat: How institutional buying supports Alector Inc stock2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Will HeartBeam Inc. stock deliver shareholder value2025 Macro Impact & Free Real-Time Market Sentiment Alerts - ulpravda.ru
How HeartBeam Inc. stock performs in stagflation2025 Volatility Report & Low Risk Investment Opportunities - Улправда
Trend Report: Will HeartBeam Inc. stock deliver shareholder valueMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Can HeartBeam Inc. stock double in next 5 yearsWeekly Profit Recap & Step-by-Step Trade Execution Guides - Улправда
Patterns Watch: Can HeartBeam Inc. stock hit analyst price targetsPortfolio Update Summary & Weekly Sector Rotation Insights - ulpravda.ru
HeartBeam Director George de Urioste Sells All Common Stock Holdings - TradingView — Track All Markets
How risky is HeartBeam Inc. Equity Warrant stock nowJuly 2025 Decliners & Expert Verified Movement Alerts - Улправда
Is HeartBeam Inc. Equity Warrant stock a bargain at current levels2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - Улправда
How institutional buying supports HeartBeam Inc. Equity Warrant stockPrice Action & High Accuracy Investment Signals - Улправда
Why HeartBeam Inc. Equity Warrant stock is a must watch in 2025Gap Up & Daily Entry Point Trade Alerts - DonanımHaber
Is HeartBeam Inc. stock dividend yield sustainable2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
Will HeartBeam Inc. Equity Warrant stock deliver consistent dividendsWeekly Profit Summary & Stepwise Trade Signal Guides - DonanımHaber
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):